Ispire's Q3 earnings report reveals massive growth

May.17.2023
Ispire's Q3 earnings report reveals massive growth
Ispire released Q3 2023 financial report with impressive YoY revenue growth of 26.9% and gross profit growth of 51.9%.

On May 16th, Ispire announced the release of their financial report for the third quarter of 2023, ending on March 31st. The company also submitted their 10-Q quarterly report to the US Securities and Exchange Commission (SEC) on May 15th. According to the report, Ispire saw a year-over-year revenue growth of 26.9%, reaching $24.1 million in the third quarter, while their gross profit increased by 51.9% to $4.5 million.


It's worth noting that the company's fiscal year end is on June 30, 2023, and they have not chosen December 31 as their fiscal year end date.


Rise in Cannabis Smoking Accessories Sales is a Popular Betting Trend


Michael Wang, the Chief Financial Officer of Ispire, has stated that the company is expecting a continuous revenue growth of 58% to 98% in the fourth quarter of their marijuana smoking devices products.


He added:


We are focused on a multi-pronged strategy aimed at increasing sales of our electronic cigarette products and developing CBD vaporization products with an emphasis on medical and recreational use.


Third Quarter Performance: Tobacco vaporization remains the main product.


In the third quarter of 2023, Ispire recorded a year-on-year revenue growth of 26.9%, reaching $24.1 million. The revenue contribution of electronic cigarette products was $16.5 million, while that of CBD-related vaporizer products was $7.6 million. Gross profit grew 51.9% year-on-year to $4.5 million. However, total operating expenses increased by 106.2% YoY, reaching $8 million compared to $3.9 million in the same period of 2022. Net loss amounted to $3.1 million, whereas in the same period of 2022, the net loss was $1 million.


Looking ahead to the future.


Ispire has provided a projection for its CBD vaporization products for the fourth quarter of 2023 (ending June 30, 2023). The company began marketing CBD vaporization products in mid-2020, with revenue reaching $7.6 million in the third quarter of 2023. It is expected that the revenue in the fourth quarter of 2023 for CBD vaporization products will increase by 58% to 98% compared to the third quarter, with projected revenue ranging between $12 million to $15 million.


According to reports, Ispire is a company that specializes in research and development, design, commercialization, sales, promotion, and distribution of branded electronic cigarettes and CBD vaporization products. The company's tobacco electronic cigarette products are sold under the Aspire brand name.


References:


Ispire Technology Inc. has released its financial results for the third quarter of 2023.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Fontem Sues FDA Over Refusal-to-File Decision for Nicotine Pouch PMTAs
Fontem Sues FDA Over Refusal-to-File Decision for Nicotine Pouch PMTAs
According to a complaint filed on March 17 in the U.S. District Court for the Northern District of Texas, Fontem US, LLC and Texas retailer OM Investment, LLC sued the Food and Drug Administration and the Department of Health and Human Services over FDA’s refusal-to-file decision for certain Zone nicotine pouch PMTAs.
Mar.19 by 2FIRSTS.ai
Canadian Conservative MP’s Promotion of Zyn Draws Opposition From Local Nicotine Pouch Brand
Canadian Conservative MP’s Promotion of Zyn Draws Opposition From Local Nicotine Pouch Brand
Conservative MP Jamil Jivani’s public support for nicotine pouch brand Zyn has drawn attention on Canadian university campuses, but Imperial Tobacco, which makes the only similar Canadian product, Zonnic, said it does not support the promotion of an unauthorized competitor.
Mar.18 by 2FIRSTS.ai
Reuters Exclusive: FDA’s Fast-Track Review of Nicotine Pouches Slows Over Youth and New-User Concerns
Reuters Exclusive: FDA’s Fast-Track Review of Nicotine Pouches Slows Over Youth and New-User Concerns
Reuters reported on April 1 that several popular nicotine pouch products still have not been cleared for sale in the United States despite a fast-track review pilot run by the U.S. Food and Drug Administration. Three sources said FDA reviewers have taken a cautious approach because of potential risks to youth and other non-tobacco users, including the possibility of driving nicotine addiction among adults who do not already smoke.
Apr.02 by 2FIRSTS.ai
Special Report | China’s New Five-Year Plan Highlights “Health-First” Strategy, Providing Policy Context for Tobacco Sector
Special Report | China’s New Five-Year Plan Highlights “Health-First” Strategy, Providing Policy Context for Tobacco Sector
China’s 2026 “Two Sessions” reviewed the draft Outline of the 15th Five-Year Plan, which proposes implementing a health-first development strategy and strengthening the effectiveness of the Patriotic Health Campaign. Although the document does not address specific industries, this public-health governance framework provides a new policy context for observing the future regulation, product strategies, and market development of China’s tobacco and next-generation nicotine sectors.
Industry Insight
Mar.08
Peru Parliament Considers Imposing up to 100% Tax on E-Cigarettes
Peru Parliament Considers Imposing up to 100% Tax on E-Cigarettes
Peru Parliament discusses bill to impose up to 100% tax on e-cigarettes, citing public health concerns. Youth usage at 15.9%.
Mar.20 by 2FIRSTS.ai
Ukrainian Committee Chair Says Nicotine Pouches Should Be Fully Banned for Sale to Minors
Ukrainian Committee Chair Says Nicotine Pouches Should Be Fully Banned for Sale to Minors
Mykhailo Radutskyi, chair of the Verkhovna Rada Committee on National Health, Medical Assistance and Medical Insurance, said nicotine pouches should be fully banned for sale to minors and their advertising should be restricted.
Apr.07 by 2FIRSTS.ai